Dr Jay Lee: NSCLC Recurrence More Costly Than Patients Who D

Jay Lee, MD, talks about financial toxicity in terms of the individual patient and in terms of the health system itself, especially in terms of non-small cell lung cancer (NSCLC) recurrence.

Related Keywords

Jay Lee , University Of California Los Angeles Health , California Los Angeles Health , Sears Medicare , Medicare Sears , Chest , Non Small Cell Lung Cancer , Nsclc , Financial Toxicity , Cost , Recurrence , Resource , Utilization ,